A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic Colorectal Cancer · Prostate Cancer Metastatic · Prostate Cancer Locally Advanced

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Krankenhaus Nordwest, Frankfurt, Germany
Contact: Study coordinator (Dragan Kiselicki, Dr.)

Study leads

Torbjörn Strom
Study Chair
CuraCell TX AB

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer

Colorectal Cancer · Colon Cancer · Rectum Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Metastatic Bone Sarcoma · Metastatic Malignant Neoplasm in the Lung · Metastatic Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Buffalo, United States

A Study of YL202 in Patients With Advanced Solid Tumors

Non Small Cell Lung Cancer · Colorectal Cancer · Cervical Cancer

Abroad (travel likely)RecruitingPHASE2

Changsha, China